MATEON THERAPEUTICS INC 4
4 · MATEON THERAPEUTICS INC · Filed Jun 12, 2017
Insider Transaction Report
Form 4
SANDAGE BOBBY W PHD
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-09+121,483→ 121,483 totalExercise: $0.51Exp: 2023-06-09→ Common Stock (121,483 underlying)
Footnotes (2)
- [F1]Dr. Sandage was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy.
- [F2]The Stock Options will vest in full on June 9, 2018, subject to Dr. Sandage's continued service on the Board of Directors as of such date.